CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that Chairman and Chief Executive Officer Paul R. Gudonis will be participating at two upcoming investor, partnering and collaboration conferences. The details for the two conferences are:

• B. Riley & Co. China Healthcare Investment Partnering Symposium at InterContinental HangZhou; corporate presentation Saturday, March 17, at 1 p.m. CST/1 a.m. EDT.In this inaugural conference, B. Riley FBR has partnered with TPP Healthcare, a leading China business development firm, to host western healthcare companies specializing in innovative technologies in areas that are vital to the growing Chinese healthcare industry, along with more than 300 Chinese healthcare strategic partners and investors.

• WearRAcon 18 at Scottsdale Plaza Resort, Arizona; corporate presentation Wednesday, March 21, at 3 p.m. MDT/5 p.m. EDT.The conference is hosted by The Wearable Robotics Association and is the only event dedicated to the wearable robotics industry. More than 200 attendees worldwide will participate to network and collaborate on the latest in wearable robotic devices.

About MyomoMyomo, Inc. is a commercial stage medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180309005067/en/

For Myomo:

[email protected]

or

Investor Relations:

PCG Advisory

Vivian Cervantes, 646-863-6274

[email protected]

or

Public Relations:

Greenough

Rachel Robbins, 617-275-6521

[email protected]

Source: Myomo, Inc.

Press Releases